Mr. Chair, I was very interested in what my colleague had to say. There are several questions that arise. We did not get a single answer out of the minister a few minutes ago. He seemed incapable of answering a single question about details with which we are already familiar because of the leaks that arrive in our offices from the negotiating table.
In addition to the concerns about supply management, which the member so ably outlined, there is a great deal of concern about pharmaceuticals and what is being said about the provincial pharmaceutical purchase plans. There could be increases of as much as 30% in the cost of drugs if all the protections afforded to the big pharmaceutical companies are extended.
So I would like to ask my colleague a question. In view of the fact that the minister was not even able to say how much this will cost Canadians all across the country and how much it will cost the medical plans in Quebec and elsewhere in Canada, is he worried about the government’s lack of a response and lack of knowledge of the details? Is he concerned as well about the price we will have to pay?